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Thirteen adherent human non-lymphocyte cell lines were tested for their susceptibility to infection by human 
immunodeficiency virus. Productive infection could be demonstrated in three of five colorectal carcinoma cell 
lines examined; the other eight human non-lymphocyte cell lines were uninfectible. A susceptible colon 
carcinoma cell line (HT29), as well as normal colonic mucosa, was shown to contain a 3.0-kilobase species of 
poly(A)+ CD4 RNA, whereas uninfectible colon carcinoma and rhabdomyosarcoma cell lines synthesized no 
detectable T4 RNA. A persistently infected colon carcinoma cell line was established that continued to produce 
progeny human immunodeficiency virus for more than 10 weeks postinfection. 
The human immunodeficiency virus (HIV) has been iso- 
lated from the peripheral blood (14, 23), semen (11, 23, 26), 
vaginal fluid (24, 25), saliva (11, 23), and tears (6) of exposed 
individuals. HIV is not a casually transmitted agent; among 
high-risk groups the virus is spread sexually or subsequent to 
parental inoculation attending the use of illicit drugs or 
administration of blood products (3). 
The clinical manifestations of HIV infection are thought to 
be due to selective tropism for the OKT41Leu-3 subset of 
human T lymphocytes both in vivo (9, 10) and in vitro (4,15). 
The virus readily infects and kills lymphocytes expressing 
the CD4 molecule. Several reports have also shown that 
HIV is capable of infecting certain established human B cell 
lines (17, 20) and monocyte-macrophage cell lines (7,13,17). 
In vivo, it has also been noted that macrophages are the 
major targets for HIV in the central nervous system (16). 
We have recently evaluated the susceptibility of several 
human and nonhuman cell lines to transfection with an 
infectious molecular clone of HIV (1). Those studies dem- 
onstrated that viral RNA and proteins were synthesized and 
assembled into infectious progeny virions in a variety of 
nonlymphoid human, monkey, mink, and mouse cells after 
the introduction of cloned proviral DNA. Expression of HIV 
was monitored by in situ hybridization or cocultivation of 
transfected cells with a CD4' human T cell line. The results 
obtained suggested the absence of any intracellular obstacle 
to viral RNA or protein synthesis and assembly and indi- 
cated that interaction of HIV particles and their receptor(s) 
during the initial stages of virus infection was the major 
determinant of cell tropism. 
During the course of the transfection studies, experiments 
were initiated to ascertain whether some of the same human 
lines could be directly infected with virus. The 14 cell lines 
listed in Table 1 were infected with the lymphadenopathy- 
associated virus (LAV) strain (2) of HIV at a multiplicity of 
infection (MOI) of approximately 0.1. A3.01 cells, a CD4+, 
IL-2-independent, and hypoxanthine-aminopterin-thy- 
midine-sensitive derivative of the CEM cell line, had previ- 
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ously been shown to support productive virus infection 
efficiently (5) and served as a positive control. Since none of 
the cell lines listed in Table 1, except A3.01, would be 
expected to express the putative receptor for HIV, it seemed 
very unlikely that progeny virions generated from a primary 
infection could spread to other cells in the culture. Virus 
infection was initially evaluated by in situ hybridization 3, 7, 
and 14 days postinfection. Only 2 of the 11 non-lymphocyte 
cell lines (the HT29 and SW480 lines, both of which were 
derived from colon carcinomas) synthesized HIV RNA in 
response to viral infection (Fig. 1A and B; Table 1). Approx- 
imately lo6 cells were analyzed in each experiment. Those 
cells containing 210 grains above background (0 to 5 grains 
per cell) were scored as positive. The percentages of HT29 
cells expressing viral RNA were 0.05, 0.1, and 0.05 on days 
3, 7, and 14 postinfection, respectively. The SW480 colon 
carcinoma line was less susceptible to viral infection, con- 
taining 0.01% positive cells on day 7. Infection of HT29 and 
TABLE 1. Susceptibility of human cell lines to HIV infection" 
-- 
Infection monitored by: 
Cell Description 
line of cells hybridization In situ Cocultivation 
A3.01 
A204 
CHP126 
SVG 
HMB2 
A549 
CAPAN-I 
SK-OV-3 
T47D 
CaCO-2 
SK-CO-1 
HT-29 
SW480 
SW1463 
T-cell leukemia 
Rhabdomyosarcoma 
Neuroblastoma 
Fetal glial 
Melanoma 
Lung carcinoma 
Pancreatic carcinoma 
Ovarian carcinoma 
Breast carcinoma 
Colon carcinoma 
Colon carcinoma 
Colon carcinoma 
Colon carcinoma 
Rectal carcinoma 
a The titer of the LAV stock used in these experiments was determined by 
end point dilution and RT assay in A3.01 cells ( 5 ) .  This stock contained 
approximately lo6 infectious units/ml. Adherent cell cultures were incubated 
with virus (MOI, 0.1) in the presence of Polybrene (2 &ml) for 16 h, at which 
time fresh medium was added. 
ND, Not done. 
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SW480 cells with LAV was repeated, and the same in situ 
hybridization results were obtained. The amount of HIV 
RNA synthesized in positive HT29 and SW480 cells, as 
monitored by the number of grains, was comparable to that 
present in positive cells from a virally infected T4' clonal 
cell line (Fig. ID) obtained by preparative flow cytornetry 
and limiting dilution of OKT4' peripheral-blood lympho- 
cytes from a normal individual. 
As a control for this experiment, RNA probes with the 
same polarity as viral mRNA were synthesized and used in 
in situ hybridization experiments. No specific annealing was 
observed in duplicate experiments with any of the 12 cell 
lines listed in Table 1. In addition, no hybridization was 
observed when RNA probes complementary to HIV mRNA 
were annealed to preparations of uninfected cell cultures 
(Fig. 1C). 
The expected absence of the T4 determinant on the 
surface of the non-lymphocyte cells listed in Table 1 would 
most likely preclude the secondary spread of input HIV. To 
amplify any progeny virions produced, CD4' A3.01 cells 
were cocultivated with the infected non-lymphocyte cultures 
21 days postinfection. Virus was detected in the HT29 and 
SW480 colon carcinoma cell lines cocultured with A3.01 
cells (Fig. 2) by reverse transcriptase (RT) assays. In addi- 
tion, production of HIV could also be demonstrated in a 
third colorectal carcinoma line, SW1463, by the cocultiva- 
tion procedure; none of the other nine non-lymphocyte lines 
examined were susceptible to virus infection (Table 1). 
Progeny virus particles appeared much earlier in HT29 cells 
than in the SW480 and SW1463 cell lines (Fig. 2). This most 
likely reflects a more efficient primary viral infection of 
HT29 cells and is consistent with the higher proportion 
(0.1%) of positive cells monitored by in situ hybridization. 
In experiments using the cocultivation-RT assay proce- 
dure to detect progeny virions, we were initially concerned 
about the possibility that the input virus inoculum might 
adsorb to or associate with the nonlymphoid cell cultures for 
long periods of time yet fail to initiate a productive infection. 
Any residual replication-competent virus present in the 
system would be capable of infecting the A3.01 cells which 
were added to amplify the HIV. This would register as a 
false-positive result. This is actually what occurred in a 
preliminary experiment in which CD4' A3.01 cells were 
cocultivated with non-lymphocyte cultures early in infec- 
tion. The "progeny" virus detected by the coculture-RT 
assay procedure in some of the infected cell lines 7 days 
postinfection clearly reflected the presence of residual input 
virus since simultaneous in situ hybridization analyses of the 
same cells were invariably negative. In contrast, when the 
A3.01 cells were added 21 days postinfection, progeny virus 
could only be demonstrated in the three colorectal carci- 
noma cell lines; HIV was never detected in the nine other 
non-lymphocyte lines examined under these conditions 
(viz., addition of A3.01 cells 21 days postinfection and 
maintenance of the cocultures for 24 days). 
An intriguing aspect of HIV infection of colorectal carci- 
noma cell lines that also validated the results obtained with 
the cocultivation-RT assay procedure was the apparent 
chronicity of virus production. A persistently infected HT29 
cell culture was established that continued to synthesize 
DAYS AFTER COCULTIVATION 
FIG. 2. Detection of progeny HIV produced in three human 
colorectal carcinoma cell lines. HT29 (O), SW480 (A), and SW1463 
(W) cells were infected with LAV at an MOI of 0.1. Twenty-one 
days postinfection, 2 x lo6 cells were cocultured with lo6 A3.01 
cells, and RT activity in the culture medium (65 p1) was monitored 
(5) on the days indicated. 
progeny virions more than 10 weeks postinfection (Table 2). 
At the present time, the state of the viral genome, as well as 
the mechanism(s) responsible for continuous virus produc- 
tion, is unknown and is being actively investigated. It is not 
clear whether HIV is chronically produced by a small 
fraction of HT29 cells or whether a minority of the cells are 
susceptible to infection, are killed during the process of viral 
replication, and release progeny particles which could then 
infect other susceptible colorectal carcinoma cells. 
The colorectal carcinoma cell lines used in this study were 
characterized in our laboratory subsequent to their receipt 
from the American Type Culture Collection (Rockville, 
Md.). By using a monoclonal antibody (COL-4) which cross- 
reacts with the carcinoembryonic antigen present in human 
colon carcinomas (21), we observed reactivity with the five 
colorectal carcinomas, the CAPAN-1 pancreatic carcinoma, 
and the SK-OV-3 ovarian carcinoma lines listed in Table 1 
by using a modification of the avidin-biotin-immunoperoxi- 
dase technique (8). 
FIG. 1. In situ hybridization of HIV-infected cells. The SW480 (A) and HT29 (B) colon carcinoma cell lines were infected with the LAV 
strain (2) of HIV at an MOI of 0.1; a cloned human T4+ cell line propagated in the presence of phytohemagglutinin (D) was infected at an MOI 
of 0.01. Cells were harvested 7 (SW480 and HT29) or 9 (infected T4' lymphocyte line) days postinfection and subjected to in situ hybridization 
as previously described (1). Mock-infected HT29 (C) cells were similarly examined. Magnification, ~ 4 0 0 .  
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TABLE 2. Persistence of HIV infection in HT29 cellsa 
Day 
cocultivation 
was initiated 
Day post 
coculture 
RT activity 
(lo3 cpm165 pl) 
" Infected HT29 cells (2 x lo6) were cocultivated with A3.01 cells (lo6) on 
the days indicated, and the kinetics of RT activity in the medium of the 
coculture were determined. 
The colorectal carcinoma cell lines were also examined for 
expression of CD4 gene products which have been shown to 
be associated with the cellular receptor for HIV (4, 15, 19). 
Despite numerous attempts, we were unable to detect T4 
proteins unambiguously on the surface of susceptible human 
colon carcinoma cell lines by using monoclonal antibodies in 
indirect immunofluorescence, flow cytometry, or immuno- 
peroxidase assays. In contrast, CD4-specific RNA could be 
demonstrated in infectible cell lines but not in those refrac- 
tory to virus infection (Fig. 3). Poly(A)+ RNA was prepared 
from HT29 (colon carcinoma), CaC02 (colon carcinoma), 
A3.01 (T4+ lymphocytic leukemia), and A204 (rhabdomyo- 
sarcoma) cell lines and analyzed by Northern blot hybrid- 
ization with a T4 cDNA probe (18). A strongly reactive 
3.0-kilobase RNA species was readily demonstrable in the 
T4+ A3.01 lymphocyte line (Fig. 3, lanes a and b). A 
comigrating species of CD4 RNA was also present in the 
infectible HT29 colon carcinoma cell line (Fig. 3, lane c) but 
not in the CaC02 colon carcinoma or A204 rhabdomyosar- 
coma cell line (Fig. 3, lanes d and e), both of which were 
refractory to HIV infection (Table 1). Based on band inten- 
sity and exposure time, we estimate the amount of stable 
CD4 RNA in HT29 cells to be approximately 2% of that 
present in the A3.01 lymphocytic leukemia line. In a sepa- 
rate experiment, poly(A)+ RNA was prepared from human 
sigmoid colon mucosa obtained from a patient undergoing 
resection for diverticulosis. The mucosa was dissected away 
from the underlying muscularis and submucosa layers. 
Gross and histological examinations revealed no evidence of 
inflammation or perforation. The 3.0-kilobase CD4-reactive 
band was readily visualized in the colon mucosal RNA 
preparation (Fig. 3, lane f). 
The demonstrated susceptibility of three of five human 
colorectal carcinoma cell lines to infection by HIV has 
potential epidemiologic implications. A series of experi- 
ments are currently under way. Colorectal biopsy specimens 
from homosexual acquired immunodeficiency syndrome pa- 
tients are being examined by in situ hybridization. Attempts 
are also being made to infect primary colon cells in culture to 
establish a more physiologic in vitro cell culture system. 
Although only a small fraction (up to 0.1%) of HT29, 
SW480, and SW1463 cells were shown to be directly infect- 
ible with HIV, this level may be significant if considered in 
the context of infection in vivo. When peripheral-blood 
lymphocytes obtained from individuals with acquired immu- 
nodeficiency syndrome-related complex or acquired immu- 
nodeficiency syndrome were evaluated by in situ hybridiza- 
tion, only 5 to 10 per lo6 cells actively synthesized viral RNA 
(12; S. Koenig and H. Gendelman, unpublished data). In a 
related experiment, we examined the effects of phytohemag- 
glutinin on the susceptibility of a T4 clonal line (obtained by 
preparative flow cytometry of normal peripheral blood lym- 
phocytes followed by limiting dilution) to infection with 
HIV. In the absence of phytohemagglutinin, only 0.01 to 
0.1% of infected T4 cells were positive by in situ hybridiza- 
tion during a 30-day observation period (S. Koenig, unpub- 
lished data). In contrast, more than 50% of the T4 cells 
actively synthesized viral RNA if they had been stimulated 
FIG. 3. T4 RNA expression in different human cells. Poly(A)+ 
RNA (5 pg) was electrophoresed through a 1% aga- 
rose-formaldehyde gel, blotted onto nitrocellulose, hybridized with 
a 32P-labeled T4 cDNA probe, and washed as previously described 
(22). RNAs were prepared from (lanes) T4+ A3.01 lymphocytic 
leukemia cells (a and b), HT29 colon carcinoma cells (c), CaC02 
colon carcinoma cells (d), A204 rhabdomyosarcoma cells (e), and 
normal human colon mucosal cells (0. Autoradiogram exposures 
were for (lanes) 5 (a), 73 (b and c), % (d and e), and 48 ( 0  h. Size 
markers were 8.2- and 3.0-kilobase murine leukemia and mink cell 
focus-forming viral RNAs (lanes a to e) and 28s and 18s rRNAs 
(lane 0 .  
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with phytohemagglutinin before infection. The small fraction 
of susceptible colorectal carcinoma cells we observed could 
reflect the low levels of CD4 expression detected in these 
cells. Since similar amounts of T4 RNA were also demon- 
strated in normal colon mucosa, it is tempting to hypothesize 
the establishment of a chronic infection at this site in vivo 
which could ultimately result in dissemination of the virus to 
cells of the lymphocytic and monocytic series and, in some 
cases, lead to the development of the acquired immunodefi- 
ciency syndrome disease complex. 
We thank B. Johnson for technical assistance and S. Rosenfeld for 
preparing the manuscript. The monoclonal antibody COL-4 and 
SVG cells were generous gifts of J. Schlom and E. 0. Major, 
respectively. 
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